00:00Hypersensitivity Neumonitis is a disease where if the antigen goes to the lungs, it will be inflammation and if the
00:11antigen exposure will be 6 months, it will be irreversible fibrosis.
00:21Hypersensitivity Neumonitis is a disease where the antigen exposure can be very common and if the antigen exposure can be
00:39very common, it will be very common.
00:42It will be very difficult to change from common diseases like asthma and COPD.
00:48When we saw the ILD India Registry, we showed it in 2012-2015 and it was found that Hypersensitivity Neumonitis
01:01patients are in a very fibrotic stage.
01:0497% of the patients have irreversible and fibrotic disease.
01:12Why?
01:12Because the antigen exposure did not get rid of the disease, the disease did not get rid of the disease.
01:18We have created a tool called HP-SARP Questionnaire, Hypersensitivity South Asian Questionnaire for Exposure.
01:29This tool can be found that we can know the patient's exposure.
01:34We can also know the exposure that we can also know the exposure.
01:38We can also know the exposure as well as the antigen exposure.
01:56If we can also know the exposure that we can also know the patient's disease, we can also know the
02:05patient's disease.
02:08are very different.
02:11Now, there was no such a validated tool in the world,
02:16and this emphasis was in our last guidelines in 2020.
02:22We made this tool for unmet need to address this tool
02:26and validate it.
02:28How did our center Japan study lead?
02:32Our center AIMS Delhi, Safdarjan Delhi, PGI Chandigarh, SGPGI Lakhnau,
02:41and Sri Lanka in Delhi.
02:43So, this is 203 patients from 6 centers
02:47and we have found that these results are 90% accurate.
02:54We have found that this antigen has been damaged
02:59and similarly, patient needs to be too anxious.
03:00With this attack, this event can be also too difficult.
03:01Please be sure to turn their channel in tigections
03:02and further ado, it is important that patient needs taking a step
Comments